I like to refer to Non-Disclosure Agreements (NDA’s) or Confidentiality Agreements (CDA’s) as the “stepchild” of all agreements since no one wants to pay much attention to them. Before I look at these agreements, I always like to know who is the party really disclosing the confidential information and then take the analysis from there.
Click here for downloadable PDF: Confidentiality Agreement Analysis
-
Recent Posts
- Assignment in a Change of Control
- Collaborative Development Financings*
- Handling IP Assets in an M&A Transaction
- Drafting IP Reps and Warranties
- Market for IP and Tech Transaction Lawyers is Heating Up
- Life Science Collaboration Agreements
- IP Ownership in Joint Development
- What is a Technology Transaction?
- License Animation Project
- Reseller vs. License Agreement
- What do Lawyers Do?
- Software Warranties and Liability
- Startup Company Forms
- My “trivial” homage to Steve Jobs
- Einstein on Branding
- Legends of Caltech
- Andy Rooney: Mathematician or Lawyer?
- Survey of Most Negotiated License Provisions
- Who Reads the Boilerplate?
- New Yorker Style Cartoon Caption Contest
- What’s the name of that dish with the lamb in it?
- NDA’s: The Stepchild Agreement
- Biotech Valuation
- Did I forget a provision?
- Patent this logo, trademark this invention ?
- 10 Considerations in a Life Science License
- David Letterman’s Top Ten
- Tetris Blocks
- The 9 Lives of Palm
- Making my own Rubik’s Cube
Pingback: A new blog offers how to analyze a confidentiality agreement | Biotech Strategy Blog